GT Biopharma (GTBP) Assets (2010 - 2026)
GT Biopharma (GTBP) posted Assets of $10 million for Q1 2026, up 276.1% from $2.66 million a year earlier and up 23.3% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma's Assets came in at $8.11 million, up 91.5% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- In prior years, GT Biopharma's Assets was $4.23 million in FY2024 (-70.0%), $14.11 million in FY2023 (-15.7%), $16.74 million in FY2022 (-48.0%) and $32.17 million in FY2021 (+468.3%).
- The Q1 2026 figure stands as the highest quarterly Assets since Q4 2023.
- On a year-over-year basis, Assets increased in two of the last six quarters, with growth averaging 21.7%.
- The strongest year-over-year quarter for Assets in the past five years was Q4 2021, with growth of 468.3%; the weakest was Q1 2025, with a decline of 73.2%.
- According to Business Quant data, Assets for the three prior quarters was $8.11 million (Q4 2025), $4.32 million (Q3 2025) and $7.12 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | GT Biopharma | 9.57 Mn | 9.57 Mn | - | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10.00 Mn |
| Dec 31, 2025 | 8.11 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Jun 30, 2025 | 7.12 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 4.23 Mn |
| Sep 30, 2024 | 6.76 Mn |
| Mar 31, 2024 | 9.91 Mn |
| Dec 31, 2023 | 14.11 Mn |
| Sep 30, 2023 | 16.15 Mn |
| Jun 30, 2023 | 18.14 Mn |
| Mar 31, 2023 | 20.09 Mn |
| Dec 31, 2022 | 16.74 Mn |
| Sep 30, 2022 | 21.07 Mn |
| Jun 30, 2022 | 24.17 Mn |
| Mar 31, 2022 | 27.44 Mn |
| Dec 31, 2021 | 32.17 Mn |
| Sep 30, 2021 | 35.80 Mn |
| Jun 30, 2021 | 39.57 Mn |
| Mar 31, 2021 | 27.64 Mn |
API Access
GT Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();